NervGen Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	May '25 May 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Market Capitalization	252	221	161	94	124	78	Upgrade
Market Cap Growth	37.18%	37.18%	71.42%	-24.19%	58.14%	36.12%	Upgrade
Enterprise Value	235	200	146	66	116	71	Upgrade
Last Close Price	3.55	3.14	2.70	1.60	2.73	2.23	Upgrade
PB Ratio	97.81	85.68	-80.10	6.98	7.36	13.23	Upgrade
P/TBV Ratio	119.34	104.55	-	7.21	7.58	14.37	Upgrade
Debt / Equity Ratio	0.04	0.04	-0.10	0.02	-	-	Upgrade
Quick Ratio	1.05	1.05	0.79	2.20	15.76	7.50	Upgrade
Current Ratio	1.13	1.13	0.83	2.27	16.16	8.21	Upgrade
Return on Equity (ROE)	-8460.20%	-8460.20%	-390.89%	-136.87%	-111.94%	-190.21%	Upgrade
Return on Assets (ROA)	-95.24%	-95.24%	-59.88%	-68.90%	-65.17%	-104.12%	Upgrade
Return on Capital (ROIC)	-3580.97%	-3580.97%	-186.22%	-94.17%	-70.43%	-118.99%	Upgrade
Earnings Yield	-9.53%	-10.87%	-13.91%	-22.07%	-10.28%	-14.28%	Upgrade
FCF Yield	-	-7.63%	-7.02%	-18.96%	-6.68%	-8.05%	Upgrade
Buyback Yield / Dilution	-13.55%	-13.55%	-12.61%	-34.00%	-22.35%	-23.97%	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.